Thousand Oaks Biopharmaceuticals Gets $45M In Series A For Biotech Manufacturing
socalTECH
JANUARY 3, 2019
Thousand Oaks- and Shanghai-based Thousand Oaks Biopharmaceuticals , a new contract manufacturing organization fort he biotech industry, said it has received $45M in a Series A financing round. The company's Chairman is Shun Luo, Ph.D.,
Let's personalize your content